Medley

What Medley does

Medley Farmacêutica Ltda. is a Brazilian generic pharmaceutical manufacturer founded in 1996 and headquartered in Campinas, São Paulo. It produces tablets, capsules, liquids, ointments, creams, and suspensions across more than eight therapeutic categories — anti-infectives, cardiovascular, central nervous system, dermatological, gastrointestinal, expectorants/anti-allergic, gynecological/urological, and anti-inflammatory/analgesic/antipyretic — and holds an estimated 8% share of Brazil's generics segment, where generics account for roughly 40% of the country's pharmaceutical market. Manufacturing is concentrated at a single ~1,800-employee Campinas production site on R. Macedo Costa, 55; the company operates under ANVISA regulatory oversight and maintains LGPD-compliant data practices.

The company's business model is sales-led distribution of generic medicines through Brazilian pharmacy retail chains, independent drugstores, and online pharmacy partners such as consultaremedios.com.br, targeting both end consumers and pharmacy/distributor buyers. Revenue derives from one-time unit sales across a portfolio of 100+ generic SKUs, with no disclosed subscription or licensing model. Medley complements its core generics franchise with branded OTC extensions (Termomed Ibup, Medalgesico, Medmulher), a nutraceutical product (Biscal D, launched in India in December 2025), and a digital mental-health engagement layer via Cássia on WhatsApp.

From 2009 until March 2026, Medley operated as a wholly-owned subsidiary of Sanofi. In March 2026, Sanofi signed a definitive agreement to sell 100% of Medley to Brazilian pharmaceutical group EMS for approximately BRL 3.2–3.6 billion (~US$660–670 million), at roughly 16x EBITDA, pending approval from Brazil's antitrust authority CADE. The deal would consolidate Medley with EMS's 23% generics share into a combined 31% market-leading position, with competing bids reported from Sun Pharma, Hypera Pharma, Biolab, and Aché.

Name

Medley

Legal name

MEDLEY FARMACÊUTICA LTDA.

Website

https://medley.com.br

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Medley Farmacêutica is a Brazilian generic pharmaceutical manufacturer founded in 1996, producing tablets, capsules, liquids, and creams across 8+ therapeutic categories from its ~1,800-employee Campinas facility and serving Brazilian pharmacy retailers and patients with an 8% generics market share.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Women’s Health (OTC Gynecologic) (HLAIADAJ)

Keywords

• Generic pharmaceuticals
• Generic medications
• OTC medicines
• Pharmaceutical manufacturing
• Generic drugs Brazil

Headquarters

HQ city

Campinas

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Generic pharmaceutical products: Medley generates revenue through the manufacture and sale of generic pharmaceutical products across multiple therapeutic categories including anti-infectives, cardiovascular, central nervous system, dermatologicals, gastrointestinal, and other medications. The company operates in Brazil's generics segment where generic medicines account for approximately 40% of the pharmaceutical market.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Medley manufactures and supplies a comprehensive portfolio of generic pharmaceutical products in multiple dosage forms (tablets, capsules, liquids, ointments, creams, and suspensions) spanning therapeutic categories including anti-infectives, cardiovascular, central nervous system, dermatological, gastrointestinal, expectorants, and gynecological/urological medications. The company also markets over-the-counter (OTC) brands such as Termomed Ibup, Medalgesico, and Medmulher, and operates the Cássia WhatsApp-based virtual mental health assistant.

Product overview

Medley is a leading Brazilian pharmaceutical company specializing in generic medications. The company produces a comprehensive portfolio of generic drugs including tablets, capsules, liquids, ointments, creams, and suspensions across multiple therapeutic categories: anti-infectives, anti-inflammatory/analgesic/antipyretic, cardiovascular, dermatological, gastrointestinal, expectorants/anti-allergic, gynecological/urological, and central nervous system medications. Medley also offers over-the-counter products including Termomed Ibup (fever relief), Medalgesico (pain and fever relief), and Medmulher (women's health). Additionally, the company offers digital health services through Cássia, a WhatsApp-based virtual mental health assistant. Founded in 1996 and acquired by Sanofi in 2009, Medley was subsequently acquired by EMS Group in 2026 for approximately BRL 3.2-3.6 billion (~$660-670 million).

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Medications Portfolio Comprehensive portfolio of generic medications including tablets, capsules, liquids, ointments, creams, and suspensions spanning therapeutic categories such as anti-infectives, cardiovascular, central nervous system, dermatological, gastrointestinal, expectorants, and gynecological/urological medications for the Brazilian population.
• Termomed Ibup Over-the-counter analgesic product providing fever relief for the whole family.
• Medalgesico Over-the-counter pain relief and fever medication for the whole family.
• Medmulher Over-the-counter medication line focused on women's health.
• Biscal D A fortified biscuit product containing Calcium and Vitamin D3 aimed at addressing nutritional deficiencies in pregnant women, lactating mothers, and postmenopausal women, launched in the Indian nutraceutical market.
• Cássia WhatsApp-based virtual mental health assistant that provides mental health tips and information to users, automating initial engagement and information delivery for mental health content.

Quantifiable outcome

• Brazil's generics market represents approximately 40% of the total pharmaceutical market

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Partnerships

Two partnerships are on record, tiered minor and core.

• AtadosminorGTM or Marketing PartnerMedley partnered with Atados, a volunteer platform, to connect NGOs with people who want to volunteer. The partnership aims to promote social causes and women's support initiatives.
• Brazilian Olympic Committee (COB - Comitê Olímpico do Brasil)coreGTM or Marketing PartnerMedley is an official sponsor of the Brazilian Olympic Committee. The partnership includes Olympic branding and athlete health support initiatives.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• EMS Group: Brazil's largest generics manufacturer with ~23% market share; in 2026 signed a definitive agreement to acquire 100% of Medley from Sanofi, making it the most directly comparable peer across product, customer base, and channel.
• Eurofarma Laboratórios: Privately-held Brazilian pharmaceutical company with a significant generics and branded-generics portfolio distributed through pharmacy retail, overlapping directly with Medley's therapeutic categories and GTM motion.
• Hypera Pharma: One of Brazil's largest pharma companies (formerly Hypermarcas), competing in generics, OTC, and consumer health; was a competing bidder for Medley in 2026 and shares the same pharmacy-channel distribution model.
• Aché Laboratórios Farmacêuticos: Brazilian pharma manufacturer across prescription, generics, and OTC categories; competing bidder for Medley in 2026 and a direct competitor for the same pharmacy and retail customers.
• Biolab Farmacêutica: Brazilian pharma company with prescription and OTC generics lines sold through retail pharmacy; also a competing bidder for Medley in 2026, indicating direct overlap in business model and customer base.

Broad incumbents

• Sanofi: Medley's former parent (2009-2026) and a global pharmaceutical major with a broader branded-prescription and vaccines focus in Brazil; comparable as a manufacturer in the same country, but not specialized in generics.
• Novartis (Sandoz): Global pharma major with a generics arm (Sandoz) operating in Brazil; broader portfolio than Medley but a relevant incumbent competing in the same generic-pharmacy channel.
• Teva Pharmaceutical Industries: World's largest generic-drug manufacturer with operations in Brazil; comparable in product type (oral solids, generics) but at a different scale and geographic footprint.
• GSK (GlaxoSmithKline Brasil): Global pharma major with established OTC and consumer-health presence in Brazilian pharmacy retail; broader portfolio than Medley, overlapping in OTC/analgesics and respiratory categories.
• Pfizer Brasil: Global pharmaceutical company with branded prescription and consumer-health operations in Brazil; comparable as a manufacturer selling through the same pharmacy channels but not focused on generics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@MedleyFarmaceutica
• Facebookfacebook.com/medleyfarmaceutica/reels
• LinkedInlinkedin.com/company/medley-ind-stria-farmac-utica-s-a
• Instagraminstagram.com/medleyfarmaceutica
• TikToktiktok.com/@medleyfarmaceutica?is_from_webapp=1&sender_device=pc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medley